| AIM IMMUNOTECH |
| USA |
| Gesundheit |
| US00901B3033 / A416YS |
| HXB (Frankfurt) |
| FRA:HXB, ETR:HXB, HXB:GR |
| - |
| https://aimimmuno.com/ |
|
AIM ImmunoTech Inc. is a biopharmaceutical company specializing in immunology-focused drug development. The company concentrates on researching and developing therapeutics for multiple types of cancers, viral diseases, immune disorders, and immune-de..
>Volltext.. |
| 9.33 Mio. EUR |
| 8.18 Mio. EUR |
| 0.08 Mio. EUR |
| -8.15 Mio. EUR |
| -11.66 Mio. EUR |
| -6.41 EUR |
| 4.02 Mio. EUR |
| 5.11 Mio. EUR |
| -9.94 Mio. EUR |
| 0.96 |
| -35.62% |
| 12.7% |
| - |
| - |
| - |
| - |
| AIM IMMUNOTECH, AIM IMMUNO |
| 24.06.26 |
|